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Abstract
Background: A liver resection under low central venous pressure (CVP) has become standard
practice; however, the benefits beyond a reduction in blood loss are not well reported. Moreover, the
precise method to achieve CVP reduction has not been established. A systematic review and meta-
analysis of randomized controlled trials (RTCs) was performed to assess the effects of CVP on clinical
outcome and to identify the optimum method of CVP reduction.
Methods: EMBASE, Medline, PubMed and the Cochrane database were searched for trials comparing
low CVP surgery with controls. The primary outcome was post-operative complications within 30 days.
Secondary outcomes included estimated blood loss (EBL), blood transfusion rates and length of stay
(LOS). Sub-group analysis was performed to assess the CVP reduction method on the outcome.
Results: Eight trials were identified. No difference was observed in the morbidity rate between the
high CVP and control groups [odds ratio (OR) = 0.96 (95% confidence interval (CI) 0.66, 1.40) P = 0.84,
I2 = 0%]. EBL [weighted mean difference (WMD) = 308.63 ml (95% CI 474.67, 142.58)
P = < 0.001, I2 = 73%] and blood transfusion rates [OR 0.65 (95% CI 0.44, 0.97) P = 0.040, I2 = 37%]
were significantly lower in the low CVP groups. Neither anaesthetic nor surgical methods of CVP
reduction were associated with a reduced post-operative morbidity.
Conclusion: Low CVP surgery is associated with a reduction in EBL; however, this does not translate
into an improvement in post-operative morbidity. The optimum method of CVP reduction has not been
identified.
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Introduction
Liver resectional surgery is frequently the only opportunity for
curative treatment of a number of primary and secondary
tumours. While it is complex surgery, mortality rates in high-
volume centres should be < 5%.1 Morbidity rates can be as
high as 45%.2
Enhanced Recovery After Surgery (ERAS) protocols after a
liver resection have increased in popularity in recent years and
several studies have highlighted not only the feasibility and
safety of fast-track protocols3 but a reduction in the length of
stay (LOS) and morbidity rates post-operatively.4 Morbidity
rates, however, remain significant, and peri-operative protocols
require optimization to minimize complications.4
It has been frequently reported that blood loss during a
liver resection is associated with increased post-operative
morbidity rates.2,5,6 Methods to reduce intra-operative blood
loss have included techniques to reduce the central venous
pressure (CVP) during a liver resection. The maintenance of
a low CVP is currently routine practice during liver
surgery.5 However, an initial review of the available data
questioned the outcome benefit of low CVP surgery beyond
a reduction in blood loss.7 Moreover, new techniques
have been introduced to reduce CVP, the efficacy of which
is not well established. This review aims to assess techniques
for CVP reduction on clinical outcomes after a liver resec-
tion.
Methods
This study was conducted according to the PRISMA guidelines
for meta-analysis conduct.8 The protocol was registered
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prospectively on the PROSPERO database for meta-analyses
(registration number CRD42014007651).
A literature search was performed independently by two
researchers of EMBASE, Medline, PubMed and the Cochrane
databases. The databases were searched from 1966 to 2014 with
the following terms: ‘central venous pressure’ or ’CVP‘ and
’liver resection‘ or ’liver surgery‘ or ’hepatic resection‘ or ’hpb’.
All abstracts were reviewed for relevance by two independent
investigators. Relevant full-text articles were subsequently
reviewed and critiqued.
Inclusion criteria
The inclusion criteria were randomized controlled trials
(RCTs) that compared significantly different CVPs or com-
pared a low CVP group with a control group and reported on
patient outcomes (morbidity, EBL and LOS) after an elective
open liver resection.
Exclusion criteria
Non-randomized trials were excluded. Trials that did not
report significantly different CVPs between groups did not
compare a low CVP with a control group or did not report
outcomes of EBL and/or morbidity rate were excluded. All
reviews were excluded. Irrelevant studies, letters, case reviews,
paediatric populations and animal studies were excluded. Non-
hepatic surgery and trials including transplant recipients were
excluded.
Intervention
The intervention investigated was a reduction in intra-operative
CVP. This was defined as a statistically significant difference in
CVP between groups, or a ’low CVP‘ group compared with a
control group. Where multiple recordings of CVP were reported,
the CVP during a liver parenchymal transection was used.
Comparator
The comparator group was the study arm where a significantly
higher intra-operative CVP was reported or the ’control‘
group. The comparator group was defined as demonstrating a
higher CVP (mmHg), regardless of absolute CVP value or
technique used to achieve CVP.
Outcomes
Primary outcome
The primary outcome was a composite end-point of the occur-
rence of one or more systemic complication within 30 days of
a liver resection. Specific blood test abnormalities were not
regarded as systemic complications.
Secondary outcome
Further comparisons were made between low CVP groups and
control groups. The mean CVP (mmHg/cm H20) during the
operation (during transection if multiple readings were pro-
vided) was compared between groups. EBL in millilitres and
LOS (recorded in whole days) were also compared between
groups. CVP-lowering protocols were also recorded and com-
pared.
Subgroup analysis
Subgroup analysis was performed according to technique of
CVP reduction: anaesthetic methods [intravenous infusion
(IVI) restriction, epidural, vasodilators and/or diuretics] and
surgical methods (IVC clamping/total or selective vascular
hepatic exclusion).
Data extraction
Abstracts were reviewed for relevance and suitability for inclu-
sion by two independent investigators. Full-text articles were
reviewed, and data were extracted using pre-designed data
extraction forms. If data were not presented in a format con-
ducive to data synthesis, the authors were contacted using the
published correspondence details. In the event of no response,
an attempt to contact authors was made by repeat email,
followed by a letter and/or phone call. Where no author
response was received, the medians and ranges were converted
to mean/standard deviation using methods described by Hozo
et al.9 The Cochrane bias risk assessment tool was used to
assess study quality.10
Statistical analysis
Statistical analysis was performed using review manager
(RevMan ver 5.2; The Nordic Cochrane Centre, Copenhagen,
Denmark). The following outcomes were treated as dichoto-
mous data and were analysed using pooled odds ratios (ORs):
primary outcome- major complication rate, intra-operative
blood transfusion requirement. The following outcomes were
treated as continuous data and were analysed with a weighted
mean difference (WMD): EBL, LOS. Statistical significance was
set at P < 0.05. Heterogeneity was assessed using I2 and X2 and
adjudged to be significant if I2 >50% and/or P < 0.05.
Results
Included trials
The PRISMA diagram of included trials is shown in Fig. 1.
Eight randomized controlled trials (RCTs) met the inclusion
criteria with 339 patients with a significantly lower CVP and
342 control patients. 11–18 Patient demographics and
indications for a hepatic resection are displayed in Table 1.
Bias assessment scores for included trials are presented in
Table 2.
Three RCTs were excluded. Ryu et al.19 maintained a low
CVP in both groups and observed the effect of milrinone on
the operative field without reporting EBL or the complication
rate; Sand et al.20 assessed the effect of patient position and
peak-end expiratory pressure (PEEP) on CVP and did not
assess EBL, morbidity or LOS; and Lin et al.21 incorporated
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five randomized groups and assessed EBL as volume per tran-
section area and did not report morbidity or LOS. It was felt
that this was not meaningfully comparable to the other
included studies and so excluded from the quantitative analy-
sis.
Evaluation of intervention
Exact CVP was not reported in two trials.15,17 In the six trials
that did report CVP,11–14,16,18 the CVP was significantly
reduced in the low CVP group (n = 291) compared with the
control groups (n = 294) [WMD 2.37 mmHg (95% CI
4.11, 0.63) P = 0.008, I2 = 92%]. No difference in in-flow
occlusion time was observed in the low CVP group (n = 223)
compared with the control group (n = 227) in the trials that
reported using it [WMD 0.21 min (95%CI 1.47, 1.88)
P = 0.810, I2 = 23%].12,16–18
Details of the trial protocols used are shown in Table 3.
Four trials utilized anaesthetic methods to reduce
CVP,11,14,15,17 three trials13,16,18 used IVC clamping to reduce
CVP and one trial12 performed an RCT comparing complete
in-flow occlusion with selective in-flow occlusion and observed
a significant difference in CVP between the two groups
Primary outcome: morbidity rate
Five studies11,12,16–18 with a total of 490 patients (low CVP
n = 243, control n = 247) reported overall systemic complica-
tion rates between the groups. There was no difference in the
overall morbidity rate between low and high CVP surgery
[OR=0.96 (95% CI 0.66,1.40) P = 0.840, I2 = 0%, Fig. 2].
Primary outcome: subgroup analysis
Subgroup analysis was performed according to the method of CVP
reduction (i.e. anaesthetic or surgical). The two trials that used
anaesthetic techniques to reduce CVP11,17 demonstrated no differ-
ence in complication rates [OR=0.6 (95% CI 0.22, 1.63) P = 0.310,
I2 = 0%]. The two trials14,15 not included in the quantitative analysis
did not report any significant differences in post-operative renal
functioning between the two groups. Sub-group analysis of the two
trials comparing IVC clamping (n = 161) versus no IVC clamping
(n = 159)16,18 demonstrated no difference in the morbidity rate
[OR 1.06 (95%CI 0.68, 1.66) P = 0.800, I2 = 0%].
Secondary outcomes
Estimated blood loss
Seven trials11–15,17,18 comprising 553 patients (low CVP n = 276,
control n = 277) reported EBL. There was a significant reduction
in EBL in the low CVP group compared with the control group
[WMD = 308.63 ml (95% CI 474.67, 142.58) P < 0.001,
I2 = 73%]. Subgroup analysis11,14,15,17 demonstrated that anaes-
thetic measures to reduce CVP (n = 98) led to a significantly
reduced EBL compared with the control (n = 98)
(WMD = 406.26 ml, CI 499.77, 321.76, P = <0.001, I2 =
52). Sub-group analysis of two trials comparing IVC clamping (n
= 139) with no IVC clamping (n = 138)13,18 showed no significant
difference in EBL between the intervention and control groups
(WMD = 88.7 ml, CI 268.02, 90.7, P = 0.330, I2 = 0%).
Intra-operative transfusion requirement
Intra-operative blood transfusion requirements were reported
in seven trials11,12,14–18 including 681 patients (low CVP
n = 339, control n = 342). Significantly fewer blood transfu-
sions were required in patients in the low CVP group
compared with the control group [OR 0.65 (95%CI 0.44, 0.97)
P = 0.040, I2 = 37%].
Length of stay
Length of stay was reported in 4 of the 8 trials12,13,17,18 with
407 patients (low CVP n = 203, control n = 204). No signifi-
cant difference was observed between the low CVP group and
the control group [WMD 1.75 days (95% CI 5.84, 2.34), P
= 0.400 I2 = 64%].
Discussion
This review demonstrates that low CVP surgery reduces EBL
and blood transfusion rates after a liver resection. However,
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articles
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Figure 1 PRISMA diagram. RCT, randomized controlled trials
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this does not correspond to improved outcomes in terms of
morbidity or hospital stay.
Two other reviews have assessed the effect of CVP reduction
on EBL.7,22 Gurusamy et al.7 and Li et al.22 meta-analysed
three and five studies, respectively, comparing low CVP with
high CVP and found a significant reduction in blood loss dur-
ing the low CVP surgery. This present review includes a fur-
ther three RCTs assessing high and low CVP,12,16,18
discriminates between the anaesthetic and surgical methodol-
ogy and investigates quantitatively the effect of CVP reduction
not only on EBL but also morbidity. This review further
demonstrates the beneficial effects of a lower CVP during a
transection when compared with higher CVPs in terms of
intra-operative blood loss and blood transfusion rates. This
consolidates the data from the previous reviews.
As well as the previous reviews of RCTs, retrospective series
exist which have shown low CVP to be safe and associated
with satisfactory EBL and outcomes23–26 and the few compara-
Table 1 Patient demographics and baseline characteristics
Wang et al.17 Liu et al.14 Liu et al.15 El-Khaboutley et al.11
Ex (n = 25) Con (n = 25) Ex (n = 30) Con (n = 30) Ex (n = 23) Con (n = 23) Ex (n = 20) Con (n = 20)
Male 19 (76) 21 (84) NA NA 14 (61) 16 (70) 11 (55) 12 (60)
Age (years) 45  15 46  12 NA NA 45  13 43  13 50  10 52  7
Indication
CLM – – NA NA – – – –
HCC 25 (100) 25 (100) 23 (100) 23 (100) 19 (95) 18 (90)
Cholangiocarcinoma – – – – – –
Other – – – – 1 (5) 2 (10)
Liver pathology
Cirrhosis 14 (56) 15 (60) NA NA NA NA 20 (100) 20 (100)
Steatosis NA NA NA NA NA NA
Resection extent
≥2 segments 21 (84) 19 (76) NA NA NA NA 13 (65) 12 (60)a
Operating time (min) 230  67 246  112 NA NA 157  39 163  61 164  42 190  24
Transection time (min) NA NA NA NA NA NA NA NA
Figueras et al.12 Zhu et al.18 Rahbari et al.16 Kato et al.13
Ex (n = 41) Con (n = 39) Ex (n = 96) Con (n = 96) Ex (n = 65) Con (n = 63) Ex (n = 43) Con (n = 42)
Male 28 (68) 31 (79) ns 37 (57) 42 (67) NA
Age (years) 62  11 61.8  13 ns 57  11 59  12. 65 (28–82) 67 (38–79)
Indication
CLM 16 (39) 15 (39) ns 35 (54) 20 (32) 6 (14) 7 (42)
HCC 17 (41) 16 (41) 19 (29) 37 (59) 35 (81) 34 (81)
Cholangiocarcinoma – – – – 1 (2) 0 (0)
Other 8 (19) 8 (21) 11 (17) 6 (9) 1 (2) 1 (2)
Liver pathology
Cirrhosis 21 (51) 18 (46) ns NA NA NA NA
Steatosis 15%19 21%23 40 (62) 39 (62) NA NA
Resection extent
≥2 segments 12 (29) b 14 (36) ns 38 (58) 37 (59) c 19 (44) 18 (43) d
Operating time (min) 219  45 207  48 162 (36) e 172 (46) e 145 (112–212) f 155 (120–221) f NA NA
Transection time (min) 65  25 60  26 NA NA 7 (4–19) 9 (5–19) 55 (15–108) 49 (7–157)
Significantly different results (P < 0.05) are highlighted in bold.
a
Major resection
b
>1 segment
c>2 segments
d
>1 segment
e
Mean (SEM)
f
Median [interquartile range (IQR)] data are otherwise presented as n(%) and the mean  standard deviation (SD) or median (range).
Ex, experimental group; Con, Control groups; NA, not reported; ns, no significant difference; CLM, colorectal liver metastases; HCC, hepatocellu-
lar carcinoma.
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Figure 2 Post-operative morbidity rates. CVP, central venous pressure; CI, confidence interval
Table 2 Bias assessment table
Random
sequence
generation
Allocation
concealment
Blinding of
participants
and personnel
Blinding of
outcome
assessment
Incomplete
outcome data
Selective
reporting
Other Bias
Wang et al.17 + + +  + + +
Liu et al.14 + +   + ? +
Liu et al.15 + + + ? + + +
El-Khaboutley et al.11 + ? ? ? + + +
Rahbari et al.16 + + +  + + +
Zhu et al.18 + + ? ? + + +
Kato et al. 13 + ? ? ? + + +
Figueras et al.12 + ? ? ? + + +
+=present; =absent; ?=unclear.
Table 3 Trial protocol details
Author Experimental
protocol
In flow
occlusion
CVP (mmHg) Control Protocol In flow
occlusion
CVP (mmHg)
Wang et al.17 IVI, Head tilt, GTN,
Furosemide,
Y 2–4 IVI Y NA
Liu et al.14 IVI, head tilt, GTN,
isoflurane, fentanyl
N 3.6  0.4 IVI N 8.9  2.1
Liu et al.15 IVI, head tilt, GTN,
furosemide,
transfusion Hb <80 g/l
N 2–4 IVI N NA
El-Khaboutley et al.11 GTN, IVI Y 3.0  0.1 IVI Y 6.9  2.8
Rahbari et al.16 IVC clamp, epidural Y 4.0  3.2 Epidural, IVI, opioids,
GTN, furosemide,
reduced PEEP,
epidural fentanyl
Y 2.6  1.8
Zhu et al.18 IVC clamp Y 4.3 (0.9)* GTN, head tilt,
furosemide, IVI
Y 4.7 (0.5)*
Kato et al.13 IVC clamp, IVI, N 4 (0–13) IVI N 6 (1–14)
Figueras et al.12 NA Y (Complete
occlusion)
6.4  3 NA Y (Selective
occlusion)
7.2  3.6
Statistically significant (P < 0.05) CVP differences highlighted in bold.
*The mean (SEM) data otherwise presented as the mean  SD or median (range).
IVI, intravenous infusion; GTN, glycerine trinitrate; PEEP, peak-end expiratory pressure; NA, Not reported.
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tive studies comparing a CVP of >5 mmHg with a CVP of
<5 mmHg during a liver transection24,27,28 retrospectively con-
cluded that those patients undergoing a resection with CVP
>5 mmHg suffered a higher EBL. These published series have
often guided practice, and low CVP surgery is regarded as a
standard practice.
Controversy remains regarding the evidence base for this
issue with several trials29–31 reporting that CVP is not associ-
ated with a reduced EBL or predictive of EBL after regression
analysis. Chibber et al.29 performed a sub-group analysis of
CVP greater and less than 5 mmHg from their cohort (all
using the same protocol) and did not observe a difference in
blood loss in living donor patients.
Moreover, two of the included trials in the current analy-
sis12,13 did not show a significant reduction in EBL and Zhu
et al.18 showed a mean reduction by only 150 ml despite all
achieving significant reductions in CVP. The reason for the
modest reduction in EBL seen in these three included trials is
potentially explained by the methodology. The overall differ-
ence in CVP between these groups was low and despite statisti-
cal significance in difference observed, a clinically significant
difference is less obvious. Zhu et al.18 and Rahbari et al.13 had
a control group as a low CVP group achieved by standard
techniques compared with the IVC clamping group. Therefore,
the comparisons in the meta-analysis were not all uncontrolled
high CVP versus low CVP (although the difference between
mean CVPs in these groups was statistically significant). When
CVP difference was larger, a more significant difference in EBL
was observed.11,14 This finding is suggestive of the importance
of well-controlled CVP and does not identify benefits associ-
ated with ultra-low CVP.
It is well established that a high blood loss and blood trans-
fusion intra-operatively has a negative effect on peri-operative
complication rates and a reduction in EBL leads to improved
post-operative outcomes.2,5 The overall meta-analysis, however,
revealed no significant difference in complication rates between
the low CVP and control groups.
An explanation for this might be the modest reduction in
EBL reported by several of the trials12,13,18 that could have
potentially influenced the analysis. The reported difference in
EBL in these trials was around 100–200 ml less than the con-
trol group. This is much less than compared with the other
included trials.11,16,17 Intuitively it can be appreciated why a
large drop in EBL could contribute to an improved outcome,
and a modest reduction would not necessarily translate into an
enhanced post-operative course.
However, it is also important to consider the methodology
of the techniques used to reduce CVP and their impact on the
outcome. Three of the trials compared IVC clamping to reduce
CVP compared with no IVC clamping. The potential hazards
of IVC clamping have not fully been investigated. A negative
effect on hepatic and renal function has not been routinely
observed;16,32 however, significantly higher rates of thrombo-
embolic events16 were reported. Such complications could
negate the benefit of low CVP and low blood loss surgery.
Considering the lack of benefit gained by this technique in
terms of EBL and outcome when compared with standard
practice, the routine performance of IVC clamping during
transection cannot be supported.
A potential explanation for the negative result in morbidity
rates from the anaesthetic studies is the small numbers of par-
ticipants in the included RCTs. Only two of the anaesthetic tri-
als reported systemic complication rates. These both showed
improved outcomes (although not statistically significant) in
the low CVP group. These trials are likely to have been under-
powered to detect a difference in systemic complications. The
subgroup analysis in the present meta-analysis also failed to
detect a significant difference in systemic complications, and a
type II error may be present. However, the two trials included
in the meta-analysis11,17 did not report significant differences
in complication rates and the two excluded trials, not report-
ing overall complication rates,14,15 did not report significant
differences in renal or hepatic function despite significant
reductions in EBL. Therefore, a clinical benefit to low CVP
surgery is not unequivocally presented by the evidence.
Another explanation for similar morbidity rates between the
groups is the potentially detrimental impact of the individual
techniques used to reduce CVP by anaesthetic meth-
ods.11,14,15,17 Intravenous (IV) fluid restriction during the tran-
section phase, glycerine trinitrate (GTN) and furosemide were
frequently utilized by the included studies. These simple meth-
ods help to maintain a state of hypovolaemia and vasodilation
reduces hepatic vein backpressure, which in turn reduces
venous bleeding during hepatic transection. The potential for
renal dysfunction has not been established.25 However, there is
a lack of prospective evidence for the efficacy and/or safety of
each individual component of such CVP lowering protocols.
Only, Ryu et al.19, and Sand et al.20 have performed assess-
ments of single anaesthetic techniques in low CVP surgery.
These studies did not fulfil the criteria for inclusion into the
meta-analysis. Sand et al.20 investigated the benefit of posi-
tional change with or without PEEP on CVP during liver
resection, finding a head-up tilt to be successful in reducing
CVP. Several studies in this review performed a positional
change to reduce CVP.14,15,17,18 Sand et al.20 found that the
CVP rose in the head-down position but fell in the head-up
position. Given that the hepatic vein pressure did not change
regardless of position, and that head-up tilt is associated with
gas embolism and haemodynamic instability,33 a positional
change is advised against.
Ryu et al.19 assessed the effect of milrinone on CVP and
the operative field. Milirone was suggested as beneficial
owing to its inotropic as well as vasodilatory effect that
would prevent the haemodynamic instability of fluid restric-
tion or vasodilation with nitrates. The results were favour-
able although the study only assessed living donors, and so
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its effect on patients with significant co-morbidities is not
yet established.
Another technique that was utilized sparingly by the
included trials was an epidural blockade. In a study by Rahbari
et al.,16 epidural anaesthesia used in the control group was
associated with a significantly reduced CVP compared with
IVC clamping. There is a lack of consensus among non-ran-
domized trials with two trials not demonstrating an effect on
blood loss when using an epidural in the CVP-lowering proto-
col29,34 and several others finding its absence associated with
improvements in EBL and morbidity.27,28,35 This is a particu-
larly pertinent issue relating to a liver resection as the opinion
regarding routine epidural use remains divided. The advocates
of an epidural would welcome its inclusion peri-operatively
owing to the perceived improvement in post-operative pain,
the attenuation of the inflammatory response and a reduction
in morbidity rates.36 However, others have voiced concerns of
coagulopathy secondary to a liver resection affecting epidural
removal,37 increased IV fluids owing to epidural-related hypo-
tension34 and increased post-operative transfusions of red
cells.34 Such disadvantages are often accepted owing to percep-
tions of improved overall outcomes. However, this concept has
been increasingly challenged as alternatives to epidurals are
becoming more widespread, and enhanced recovery protocols
improve the speed of recovery often without the need for an
epidural.38,39 This is, therefore, an area that warrants prospec-
tive investigation to clarify the effect of an epidural on CVP
and outcome after a liver resection.
An additional point to consider is the effect of in-flow
occlusion. All but Kato et al.13 combined IVC clamping within
flow occlusion. This could potentially result in a deleterious
effect on outcome owing to a potential ischaemia-associated
liver injury.40 This suspicion is further supported by three
RCTs12,41,42 whereby selective inflow occlusion rather than
complete in-flow occlusion was associated with a significantly
reduced post-operative morbidity. All maintained a CVP of less
than 5 mmHg, there was no difference in blood loss, but
Ni et al.42 and Fu et al.41 reported a reduction in morbidity in
the selective Pringle groups when compared with the Pringle
groups. This, therefore, points to other areas of protocol opti-
mization to consider when CVP has been optimized below
5 mmHg.
Whie the results of the present meta-analysis did not dem-
onstrate a significant reduction in morbidity in the low CVP
group, other advantages of low CVP surgery merit discussion.
A reduction in bleeding during transection has practical impli-
cations that warrant consideration. Patient preference to avoid
a blood transfusion is important. Furthermore, surgeons’
assessment of the operative field and ease of surgery are impor-
tant factors when attempting to improve short- and long-term
outcomes. Such qualitative metrics was not assessed in the
included trials, and these outcomes may be the subject of
future research.
The main limitation of this review is the heterogeneity of
the included studies. The anaesthetic studies assessed a CVP of
over five with a CVP of <5 mmHg. The IVC clamping studies,
despite significant differences in CVP, assessed a CVP of
<5 mmHg in both groups. It is, therefore, unsurprising that
little difference is seen in the outcome. However, the primary
aim of all the included trials was to assess the effect of CVP
lowering. Therefore, the included trials provide an accurate
reflection of current practice in hepatic surgery.
In summary, this review and meta-analysis shows that low
CVP surgery effectively results in reduced blood loss and
transfusion requirement during a liver resection and its
practice is supported. However, no improvement in clinical
outcomes is associated with this, and this may be affected by
methodology. IVC clamping does not improve outcome over
low CVP surgery achieved by standard CVP lowering tech-
niques and is not advised. The optimum technique to achieve
a CVP reduction is not known with controversies existing
regarding the correct anaesthetic technique and potential
disadvantages of using the Pringle manoeuvre. Prospective,
randomized trials are required to establish precise protocol
components when attempting to optimize outcomes after a
liver resection.
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